Therapeutic
Biological Products
Mailing Address for Advertising
and Promotional Labeling
All information related to advertising and promotional labeling
including FDA Form 2253-Transmittal of Advertisements and
Promotional Labeling for Drugs and Biologics for Human Use;
Submission for the Dissemination of Information on an Unapproved/New
Use per 21 CFR 99.201; complaints, requests for advisory, and
response to enforcement actions shall be sent to:
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Drug Marketing, Advertising and Communication
5901-B Ammendale Road
Beltsville, MD 20705-1266
Therapeutic Biological
Products
Date created: October 9, 2003, updated August
29, 2005 |
